ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.
Angela J Ziebarth et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this papercites it